Authors
Latest:
Presbia unveils implantable micro-lensPresbia Coöperatief U.A. of Amsterdam unveiled an implantable micro-lens treatment (Flexivue System) for presbyopia at the European Society of Cataract and Refractive Surgeons annual meeting.
Latest:
Patient presents with bilateral blurred visionA 51-year-old Latin woman presented to the Bascom Palmer Eye Institute with a complaint of blurry vision in both eyes over the last 6 months. The visual loss was described as gradual, affecting both distance and near vision. The patient denied other symptoms of pain, redness, photophobia, floaters, or photopsias. The patient also denied any relevant medical history, medication use, or history of trauma. Family history was non-contributory. Ocular history was significant for "poor vision in my right eye since childhood," but no history of strabismus existed. The patient worked as a clerk at a dairy company and had a 15 pack-year smoking history, with occasional alcohol use.
Latest:
Patient presents with bilateral blurred visionA 51-year-old Latin woman presented to the Bascom Palmer Eye Institute with a complaint of blurry vision in both eyes over the last 6 months. The visual loss was described as gradual, affecting both distance and near vision. The patient denied other symptoms of pain, redness, photophobia, floaters, or photopsias. The patient also denied any relevant medical history, medication use, or history of trauma. Family history was non-contributory. Ocular history was significant for "poor vision in my right eye since childhood," but no history of strabismus existed. The patient worked as a clerk at a dairy company and had a 15 pack-year smoking history, with occasional alcohol use.
Latest:
Vision Expo West: Win big in VegasVision Expo West takes place from Sept. 30 to Oct. 3 at the Sands Expo and Convention Center, Las Vegas.
Latest:
Advance Beneficiary Notice shifts responsibility for paymentBased on a physician's knowledge of the risk of non-payment, Medicare's Advance Beneficiary Notice should be used when the physician believes the service is unlikely to be covered since it may not be medically necessary or reasonable. The ABN explains to the patient that even though Medicare does not pay for a certain item or service does not mean that the patient shouldn't have it. The –GA modifier should be used on the ABN. If –GA is not appended, the patient will be informed in the Explanation of Benefits that they are not responsible for payment.
Latest:
EyePod: Navigating the premium lens landscape from pipeline to practiceIn this episode, Neda Shamie, MD, and Peter J. McDonnell, MD, discuss the benefits and challenges of implementing the many options from the premium lens pipeline into practice, emphasizing the importance of customization based on patients' lifestyles and expectations, while also addressing concerns and sharing their positive experiences with the evolving technology in the field.
Latest:
Eyes with ocular involvement from SJS/TEN mandate acute and chronic carePatients are at risk for developing severe dry eye and ocular surface disease.
Latest:
Which retirement plan is right for your practice?If you own a small business (such as a medical practice), many retirement plan alternatives are available to assist you and your eligible employees with retirement planning. To make an informed decision on which plan is right for your practice, review the differences carefully before choosing.
Latest:
A 19-year-old female has transient black spots, headachesA 19-year-old Latin female presented to the Bascom Palmer emergency room complaining of transient black spots in the right eye.
Latest:
The ins and outs of treating ‘financial cataracts’Conducting a thorough financial examination may help clinicians to see their finances as clearly as their patients see the world after cataract surgery.
Latest:
The ins and outs of treating ‘financial cataracts’Conducting a thorough financial examination may help clinicians to see their finances as clearly as their patients see the world after cataract surgery.
Latest:
The ins and outs of treating ‘financial cataracts’Conducting a thorough financial examination may help clinicians to see their finances as clearly as their patients see the world after cataract surgery.
Latest:
Changing landscape of keratoconus managementAlternate methods of screening may lead to earlier diagnosis of disease.
Latest:
OCT finds niche in glaucoma diagnosis, managementTechnology makes great tool, requires extra vigilance with co-existing disease
Latest:
Choroidal hypoperfusion defects in retinopathy of prematurity: A new fluorescein angiographic findingROP can be a disease that affects both the retinal and choroidal vasculatures.
Latest:
Physicians sort out pros and cons of several new IOLs on the market“Real talk” on new devices gives surgeons, patients decision-making insights
Latest:
Glaucoma: Hyperemia a common cause for medication changesHyperemia is one of the main reasons why patients with glaucoma do not adhere to or persist with their topical therapeutic regimen. Patients end up switching to another possibly more tolerable medication, and the changing of medications has significant financial implications. Latanoprost has the lowest incidence of hyperemia among the prostaglandin analogs. Patient adherence is crucial in a chronic progressive disease such as glaucoma, where non-adherence can lead to visual loss and decline in quality of life, creating societal health and economic burdens.
Latest:
ASCRS/ASOA annual meeting setting sail to San DiegoThe 2019 annual meetings of the American Society of Cataract and Refractive Surgery and the American Society of Ophthalmic Administrators will be held May 3 to 7 in San Diego.
Latest:
ARVO to launch new journalThe Association for Research in Vision and Ophthalmology is launching a third journal, Translational Vision Science & Technology, an online-only, peer-reviewed journal emphasizing multidisciplinary research that bridges the gap between basic research and clinical care.
Latest:
Convey the need but don't forget the funToday's successful physicians not only understand the role of branding in the practice management mix but also realize that establishing, burnishing, and communicating the practice's positioning is essential.
Latest:
Genentech decision expands access to bevacizumabGenentech has agreed to allow its wholesale distributors to ship its bevacizumab (Avastin) to compounding pharmacies or other locations of a physician's choice.
Latest:
Improving surgical outcomes for pediatric patientsTechniques, technologies minimize complications and guide counseling, care.
Latest:
Style versus substanceAny asset protection plan that will truly stand up if challenged must have economic substance.
Latest:
Emerging technology aids diabetic retinopathy screeningOphthalmologists should take a proactive approach toward the screening, management, and early treatment of diabetic retinopathy.
Latest:
Dry eye brimming with innovationThe acceleration of research focused on dry eye over the past several decades has led to an increase in knowledge regarding the pathophysiology of the disease.
Latest:
Specialists offer pearls for physicians’ financial healthChanges in health care industry can affect the way ophthalmologists plan their finance.
Latest:
EURETINA 2022: LIGHT study offers first analysis of gene therapy for RPE65 inherited retinal dystrophiesAt the 22nd EURETINA World Congress in Hamburg, Germany,Isabelle Audo, MD, reported that voretigene neparvovec used to treat patients with a RPE65-related inherited retinal dystrophy, showed good safety and efficacy at the 1-year time point of the LIGHT Study.
Latest:
What patients need to know about cataract surgeryUday Devgan, MD, FACS, of Devgan Eye Surgery in Los Angeles and Beverly Hills, CA, answers a few key questions his patients have asked when considering cataract surgery.
